Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Merxin Ltd specializes in the design and supply of generic and custom drug delivery device platforms—primarily various types of pharmaceutical-grade inhalers. Their products are used globally by pharma companies to deliver both generic and novel therapies via the pulmonary route. They have successfully launched several AB-rated substitutable generic devices targeting major respiratory indications such as asthma and COPD. Their expertise includes rapid development-to-market timelines through partnerships with manufacturers like Gerresheimer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Merxin Ltd.